Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices, including CRT devices, leadless pacemakers, and S-ICDs These advancements will contribute to overall market expansion. However, economic constraints across the region will limit revenue growth to some extent, impacting the widespread adoption of high-cost technologies.

This Medtech 360 Report provides comprehensive data and analysis on the state of the Asia Pacific CRM device market from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…